Assembly Biosciences
(NASDAQ) ASMB
Assembly Biosciences Financials at a Glance
Market Cap
$542.99MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$71.10M
Net Income (TTM)
-$6.38M
EPS (TTM)
-$1.20
P/E Ratio
-22.82
Dividend
$0.00
Beta (Volatility)
0.98 (Low)
Dividend
$0.00
Beta (Volatility)
0.98 (Low)
Price
$27.49
Volume
169,991.996
Open
$27.86
Price
$27.49
Volume
169,991.996
Open
$27.86
Previous Close
$27.40
Daily Range
$26.45 - $27.99
52-Week Range
$16.90 - $39.71
Estimated Earnings Date
Aug 5, 2026
Dividend
$0.00
Beta (Volatility)
0.98 (Low)
Price
$27.49
Volume
169,991.996
Open
$27.86
Previous Close
$27.40
Daily Range
$26.45 - $27.99
52-Week Range
$16.90 - $39.71
Estimated Earnings Date
Aug 5, 2026
ASMB News
ASMB: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Assembly Biosciences
Industry
Biotechnology
Sector
Health CareEmployees
73
CEO
Jason A. Okazaki
Website
www.assemblybio.comHeadquarters
South San Francisco, CA 94080, US
ASMB Financials
Key Financial Metrics (TTM)
Gross Margin
53.91%
Operating Margin
-19.05%
Net Income Margin
-8.98%
Return on Equity
-4.21%
Return on Capital
-5.79%
Return on Assets
-2.71%
Earnings Yield
-4.38%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$542.99MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
19.82M
Volume
169.99K
Avg. Volume
200.78K
Financials (TTM)
Gross Profit
$38.33M
Operating Income
-$13.55M
EBITDA
-$6.26M
Operating Cash Flow
-$39.75M
Capital Expenditure
-$85.00K
Free Cash Flow
-$39.84M
Cash & ST Invst.
$226.60M
Total Debt
$2.49M
Assembly Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$8.21M
-12.8%
Gross Profit
$8.19M
+250.7%
Gross Margin
99.68%
N/A
Market Cap
$542.99MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$7.44M
N/A
Employees
73
N/A
Net Income
-$9.08M
-3.0%
EBITDA
-$9.05M
-3.1%
Quarterly Fundamentals
Total Cash
$226.60M
+148.9%
Total Debt
$2.49M
-17.5%
Accounts Receivable
$451.00K
+12.8%
Inventory
$0.00
N/A
Long Term Debt
$1.90M
-23.7%
Short Term Debt
$590.00K
+11.5%
Return on Assets
-2.71%
N/A
Return on Invested Capital
-6.76%
N/A
Free Cash Flow
-$22.12M
+5.6%
Operating Cash Flow
-$22.10M
+5.7%